Mydecine Innovations Group Inc.
Mydecine Innovations Group Inc.
Liste d'échange:
CSEStatut:
Active
Industrie:
Diversified IndustriesSymbole:
MYCOAssociated Securities:
Mydecine Innovations Group Inc. 12FEB2024 WarrantsIndice CSE:
NoDevise:
CAD Mydecine Innovations Group Inc. is a publicly traded, pre-revenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was founded to increase physicians' access to serotonin-modulating medicine. Recent research has demonstrated the therapeutic potential of psychedelic substances such as psilocybin and MDMA for treating intractable conditions such as pain, anxiety, depression, addiction, and PTSD, along with neurodegenerative disorders. Mydecine believes these compounds can be safer, more effective, and more accessible for patients and medical professionals through modern drug chemistry paired with artificial intelligence (AI). Mydecine is developing innovative medications for target indications with high mortality rates that have lacked innovation for decades and are controlled by dominant corporations.
Mydecine Innovations Group Inc. (MYCO)
0.005
0.00 (0.00%)
Mydecine Innovations Group Inc. (MYCO)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Quantité demandé
2,561,000
Cours acheteur
0.005
Cours vendeur
0.01
Quantité offerte
1,079,000
Volume
0
Dernier prix
0.005
Écart minimum
variation nette
Clôture précédente
0.005
Ouverture
0.00
Day High
0.00
Day Low
0.00
Haut 52 semaines
0.025
Bas 52 semaines
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Quantité demandé
250,000
Cours acheteur
0.005
Cours vendeur
0.01
Quantité offerte
50,000
Volume
102,060
Dernier prix
0.005
Écart minimum
variation nette
-0.005
Clôture précédente
0.01
Ouverture
0.005
Day High
0.005
Day Low
0.005
Haut 52 semaines
Bas 52 semaines
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Quantité demandé
2,561,000
Cours acheteur
0.005
Cours vendeur
0.01
Quantité offerte
1,079,000
Volume
0
Dernier prix
0.005
Écart minimum
variation nette
Clôture précédente
0.005
Ouverture
0.00
Day High
0.00
Day Low
0.00
Haut 52 semaines
0.025
Bas 52 semaines
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Quantité demandé
250,000
Cours acheteur
0.005
Cours vendeur
0.01
Quantité offerte
50,000
Volume
102,060
Dernier prix
0.005
Écart minimum
variation nette
-0.005
Clôture précédente
0.01
Ouverture
0.005
Day High
0.005
Day Low
0.005
Haut 52 semaines
Bas 52 semaines
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| TD Securities Inc. | 16,000 | 0.005 | 0.01 | 246,000 | RBC Capital Markets |
| RBC Capital Markets | 30,000 | 0.005 | 0.01 | 1,000 | Desjardins Securities Inc. |
| RBC Capital Markets | 100,000 | 0.005 | 0.01 | 5,000 | Anonymous |
| BMO Nesbitt Burns Inc. | 280,000 | 0.005 | 0.01 | 1,000 | Desjardins Securities Inc. |
| TD Securities Inc. | 450,000 | 0.005 | 0.01 | 20,000 | TD Securities Inc. |
| TD Securities Inc. | 100,000 | 0.005 | 0.01 | 1,000 | TD Securities Inc. |
| Desjardins Securities Inc. | 88,000 | 0.005 | 0.01 | 99,000 | TD Securities Inc. |
| Desjardins Securities Inc. | 30,000 | 0.005 | 0.01 | 4,000 | Desjardins Securities Inc. |
| National Bank Financial Inc. | 29,000 | 0.005 | 0.01 | 163,000 | TD Securities Inc. |
| Questrade Inc. | 1,000 | 0.005 | 0.01 | 81,000 | Desjardins Securities Inc. |
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| Anonymous | 8,000 | 0.005 | 0.01 | 48,000 | Anonymous |
| Anonymous | 102,000 | 0.005 | 0.01 | 2,000 | Anonymous |
| Anonymous | 140,000 | 0.005 | 0.00 | 0 | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 47 | 2,561,000 | 0.005 | 0.01 | 1,079,000 | 23 |
| 0 | 0 | 0.00 | 0.015 | 199,000 | 9 |
| 0 | 0 | 0.00 | 0.02 | 484,000 | 10 |
| 0 | 0 | 0.00 | 0.025 | 624,000 | 7 |
| 0 | 0 | 0.00 | 0.03 | 100,000 | 1 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 3 | 250,000 | 0.005 | 0.01 | 50,000 | 2 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
|---|---|---|---|---|---|---|
| Mar 25, 16:21 | 0.005 | 0.00 | 102,000 | Anonymous | Ventum Financial Corp. | CSE2 |
| Mar 24, 15:49 | 0.005 | 0.00 | 10,000 | TD Securities Inc. | Anonymous | CSE |
| Mar 24, 15:11 | 0.01 | 0.005 | 10,000 | TD Securities Inc. | Anonymous | CSE2 |
| Mar 24, 13:30 | 0.005 | 0.00 | 180,000 | Anonymous | RBC Capital Markets | CSE |
| Mar 24, 13:30 | 0.005 | 0.00 | 10,000 | Anonymous | RBC Capital Markets | CSE |
Information d'entreprise
Addresse
1890 – 1075 West Georgia Street
Vancouver, BC V6E 3C9
CanadaTéléphone
604-687-2038Courriel
hello@mydecineinc.comURL
http://www.mydecineinc.comDate d’inscription à la cote
Vendredi, octobre 6, 2023
Agent de transfert
Endeavor Trust CorporationVérificateur
HDCPA Professional CorporationSEDAR Information
Type de dossier
Tout
Management's Discussion & Analysis
Financial Statements
News Releases
Material Change Report
Délai
@count semaine@count mois3 month6 month@count annéeTout le temps
Information d'entreprise
Addresse
1890 – 1075 West Georgia Street
Vancouver, BC V6E 3C9
CanadaTéléphone
604-687-2038Courriel
hello@mydecineinc.comURL
http://www.mydecineinc.comDate d’inscription à la cote
Vendredi, octobre 6, 2023
Agent de transfert
Endeavor Trust CorporationVérificateur
HDCPA Professional CorporationCapitalisation
Capitalisation:
61755385Réservé à l'émission:
2861428Company Officers
David Joshua Bartch, President and Chief Executive Officer
John Ross, Chief Financial Officer and Corporate Secretary
Damon Michaels , Chief Operations Officer
Robert Roscow, Chief Science Officer
Rakesh Jetly, Chief Medical Officer
Jim Gunning, Chief Marketing Officer
Communiqués de presse
